Updated:
ProAssurance
ProAssurance was founded in 2001 by Edward L. Rand, Jr., who continues to serve as President and CEO. The Birmingham-based insurer specializes in medical...
ProAssurance
ProAssurance was founded in 2001 by Edward L. Rand, Jr., who continues to serve as President and CEO. The Birmingham-based insurer specializes in medical professional liability (MPL), providing coverage to physicians, senior care facilities, and other healthcare providers. Its operations extend through subsidiaries including ProAssurance Indemnity Company and ProAssurance Casualty Company, with an additional office in Lancaster, Pennsylvania, housing the Eastern Alliance headquarters. The firm's underwriting strategy concentrates on three core lines: healthcare professional liability, legal professional liability, and workers' compensation insurance. Its MPL book has been built since 1976 through predecessor entities, making it one of the longest-tenured carriers in the space. ProAssurance previously participated in Lloyd's of London's Syndicate 1729 as a capital provider, though that syndicate is now in run-off. The firm's investment portfolio, managed internally, focuses on US fixed-income and equity assets to support its claims-paying ability. In March 2025, The Doctors Company entered into a definitive agreement to acquire ProAssurance in an all-cash transaction valued at approximately $1.3 billion. The deal, expected to close in 2025, combines two mutual-like insurers that together cover roughly 150,000 healthcare professionals. ProAssurance maintains memberships in the American Property Casualty Insurance Association and the Medical Professional Liability Association, and operates the ProAssurance Group Charitable Foundation for philanthropic activities. The pending acquisition represents the most structural differentiator: ProAssurance will transition from a publicly traded insurer to part of a physician-owned mutual, shifting its governance from shareholder returns to policyholder-first capital management. This hybrid path — public company acquired by a mutual — is uncommon in insurance M&A and will reshape how the combined entity deploys its investment portfolio and approaches underwriting discipline in the MPL sector.
General information
Firm type
Insurance
Year founded
2001
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Birmingham
Corporate office
100 Brookwood Place, Birmingham, AL 35209, United States
Additional offices
Lancaster, PA, United States
Principals
Edward L. Rand, Jr.
President and Chief Executive Officer
Sector focus
Frequently asked questions
Who runs investment decisions at ProAssurance?
Edward L. Rand, Jr., as President and CEO, oversees the firm's investment portfolio alongside the broader executive team. ProAssurance manages its assets internally, with a focus on fixed-income and equity holdings that support its property and casualty underwriting liabilities. Specific details on the investment committee structure are not publicly disclosed.
Why is The Doctors Company acquiring ProAssurance?
The Doctors Company agreed to acquire ProAssurance in March 2025 for approximately $1.3 billion in an all-cash deal. The transaction combines two of the largest medical professional liability insurers in the US, creating scale in a consolidating MPL market. The combined entity aims to strengthen underwriting capacity and expand geographic reach for physician and healthcare facility coverage.
What is ProAssurance's investment approach?
ProAssurance manages an investment portfolio primarily composed of US fixed-income and equity securities, designed to support its insurance liabilities. The firm does not publicly disclose a detailed asset allocation, but its holdings function as a conservative, claims-paying reserve typical of property and casualty insurers. The portfolio is overseen internally rather than outsourced to external managers.
What is ProAssurance's relationship with Lloyd's of London?
ProAssurance was previously a lead capital provider for Lloyd's Syndicate 1729, though that syndicate is now in run-off. The firm no longer actively participates in the Lloyd's market. This reflects a pullback from international specialty lines to focus on its core US medical professional liability business.
How does the acquisition affect ProAssurance's existing policies?
The Doctors Company has stated that existing ProAssurance policies will remain in force and claims handling will continue without interruption. As a mutual insurer, The Doctors Company operates for the benefit of its policyholder-owners, which may shift long-term underwriting priorities toward physician interests over shareholder returns. Regulatory approvals are required before the deal closes, expected in 2025.
What philanthropic activities is ProAssurance involved in?
ProAssurance operates the ProAssurance Group Charitable Foundation, which supports community and healthcare-related causes. The foundation functions separately from the insurance underwriting entities. No specific grantmaking figures or focus areas are publicly disclosed.
What investment stages or asset classes does ProAssurance avoid?
ProAssurance's investment portfolio is restricted by insurance regulations requiring capital preservation and liquidity to meet policyholder claims. The firm does not invest in venture capital, private equity, or other illiquid alternatives as part of its core strategy. Its focus remains on publicly traded fixed-income and equity securities within the United States.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on investors?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: